MRK-016

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by BsherrAWBBOT (talk | contribs) at 22:23, 28 July 2020 (→‎References: orphaning per Wikipedia:Templates for discussion/Log/2020 July 17#Template:Nootropics, plus general fixes). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

MRK-016
Names
IUPAC name
3-tert-Butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)pyrazolo(1,5-d)(1,2,4)triazine
Identifiers
3D model (JSmol)
ChemSpider
  • InChI=1S/C17H20N8O2/c1-10-6-11(23-27-10)15-21-19-7-12-14(17(2,3)4)16(22-25(12)15)26-8-13-18-9-20-24(13)5/h6-7,9H,8H2,1-5H3
    Key: QYSYOGCIDRANAR-UHFFFAOYSA-N
  • CN1N=CN=C1COC1=NN2C(C=NN=C2C2=NOC(C)=C2)=C1C(C)(C)C
Properties
C17H20N8O2
Molar mass 368.401 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

MRK-016 is a selective α5 subunit-containing GABAA negative allosteric modulator that has nootropic properties. It has been found to produce rapid, ketamine-like antidepressant effects in animal models of depression.[1]

See also

References

  1. ^ Fischell, Jonathan; Van Dyke, Adam M; Kvarta, Mark D; LeGates, Tara A; Thompson, Scott M (2015). "Rapid Antidepressant Action and Restoration of Excitatory Synaptic Strength After Chronic Stress by Negative Modulators of Alpha5-Containing GABAA Receptors". Neuropsychopharmacology. 40: 2499–2509. doi:10.1038/npp.2015.112. ISSN 0893-133X. PMC 4569955. PMID 25900119.


Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=MRK-016&oldid=970045923"